Your browser is old and is not supported. Upgrade for better security.
Wefunder logo

Gerostate Alpha (YC S18)

A pharmaceutical company dedicated to treating aging and age-related disease

Pitch Video
Investor Panel

Investor Panel

Shu interviewed Gerostate Alpha (YC S18) on June 8, 2021. Play Video
Shu Li
CEO and co-founder of Petri-Bio
says, "The founding team members are all very successful scientists, and they are trying to provide a completely novel solution to the aging problem. It's very exciting!"
says, "For crowdfunding, I think it would help the audience to understand the timeline and business model if you could talk a little more about the licensing and B2B potential as well."

What Investors Say

Invested $25,000 this round
I’m very excited to be the lead investor of Gerostate Alpha, a cutting edge company developing therapeutics for aging and longevity. I’ve visited the team at their amazing labs at the Buck Institute, in Novato, CA, where they are incubating. To say I’m impressed is an understatement - it's an amazing facility and the founders at GSA are incredibly impressive. The platform they have built is very compelling, and is likely to deliver high value drug candidates over the next few years. I'm honored to be along for the ride, as I truly believe that GSA is creating enormous value for investors and humanity.

In the News

Gerostate Alpha: "Our phenotype is lifespan" - Longevity.Technology
January 19, 2021
Following yesterday's introduction to Gerostate Alpha, today we continue our interview with two of the company's founders, Simon Melov and Mark Lucanic. Longevity.Technology: Today's article covers the co-founders' comments concerning the company's fundraising plans, but first focuses on the unique discovery approach that Gerostate Alpha has developed.
"The major modulators of aging remain to be discovered" - Longevity.Technology
January 18, 2021
Deep in the labs of the world-renowned Buck Institute for Research on Aging, a company is growing. Founded by a team of senior Buck scientists, Gerostate Alpha is steadily working on the development of new drugs that target aging.
What People Say